Text Size

Surgical Versus Medical Treatment of Acromegaly

This study has been completed.
Sponsor:
Information provided by:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT01000090
First received: October 21, 2009
Last updated: June 22, 2011
Last verified: June 2011
History of Changes
  Purpose

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone).

Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.


Condition
Acromegaly

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Surgical Versus Medical Treatment of Acromegaly: Effects on Biochemical Markers

Further study details as provided by University of Aarhus:

Biospecimen Retention:   Samples Without DNA

Serum


Enrollment: 63
Study Start Date: October 2009
Study Completion Date: June 2011
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts
Acromegaly patients, somatostain analogues
Acromegaly patients, surgery

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Acromegalic patients followed in the outpatient clinic at Århus University Hospital, Medical Department M

Criteria

Inclusion Criteria:

  • Acromegaly diagnosis
  • treated with Somatostatin analogues or surgery
  • in treatment control

Exclusion Criteria:

  • treatment with GH-antagonist
  • never treated
  • not in treatment control
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01000090

Locations
Denmark
Århus University Hospital, Medical department M
Århus, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Study Director: Kristine Z Rubeck, stud. med. Medical department M, Århus University Hospital
Principal Investigator: Jens Otto L Jørgensen, MD Medical department M, Århus University Hospital
Study Director: Michael Madsen, MD Medical department M, Århus University Hospital
Study Director: Sanne Fisker, MD Medical department M, Århus University Hospital
Study Director: Caroline Adreasen, MD Medical department M, Århus University Hospital
Study Director: Jan Frystyk, MD Medical department M, Århus University Hospital
  More Information

No publications provided

Responsible Party: Jens Otto Lunde Jørgensen, Århus University Hospital
ClinicalTrials.gov Identifier: NCT01000090     History of Changes
Other Study ID Numbers: kzr200809
Study First Received: October 21, 2009
Last Updated: June 22, 2011
Health Authority: Denmark: Danish Dataprotection Agency

Keywords provided by University of Aarhus:
Acromegaly
Somatostatin analogues
Treatment

Additional relevant MeSH terms:
Acromegaly
Bone Diseases, Endocrine
Bone Diseases
Musculoskeletal Diseases
Hyperpituitarism
Pituitary Diseases
 Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on June 17, 2013